Do conventional pathologic features lose their prognostic significance following postoperative radiation therapy in pathologic stage I-II endometrial adenocarcinoma?

International Journal of Cancer

Volumn 90, Issue 4, 2000, Pages 224-230

  Mundt, Arno J ^a   Connell, Philip P ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Endometrial carcinoma; Prognostic factors; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RADIOISOTOPE THERAPY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VAGINA; VASCULAR NEOPLASMS;

EID: 0033851250     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000820)90:4<224::AID-IJC5>3.0.CO;2-P     Document Type: Article

References (47)

1. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology study
2. Pathologic models to predict outcome for women with endometrial adenocarcinoma: The importance of the distinction between surgical stage and clinical stage - A gynecologic oncology group study
3. Which prognostic factors influence the outcome of patients with surgically staged endometrial cancer treated with adjuvant radiation?
4. A phase II randomized study of surgery, versus surgery plus adjunctive radiation therapy in intermediate-risk endometrial adenocarcinoma (GOG no 99)
5. FIGO - Stages 1988 revision
6. Non-parametric estimation from incomplete observations
7. Regression models for life-tables (with discussion)
8. Treatment of stage I adenocarcinoma of the endometrium by hysterectomy and adjuvant irradiation: A retrospective analysis of 304 patients
9. Treatment failure in endometrial carcinoma
10. Influence of preoperative irradiation on failures of endometrial carcinoma with high risk of lymph node metastasis
11. Carcinoma of the endometrium. V. An analysis of prognosticators in patients with favorable subtypes and stage I disease
12. Residual carcinoma in the surgical specimen of patients with endometrial adenocarcinoma undergoing preoperative radiation therapy. A study of 80 patients and a literature review
13. Predictors of distant recurrence in clinical stage I or II endometrial carcinoma treated by combination surgical and radiation therapy
14. Stage I corpus cancer: Is teletherapy necessary?
15. The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer
16. Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium
17. Predictors of recurrence in surgical stage II endometrial adenocarcinoma
18. Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: Implications for therapy
19. Endometrial carcinoma: Analysis of recurrence in patients treated with a strategy minimizing lymph node sampling and radiation therapy
20. Endometrial adenocarcinoma, adjuvant radiotherapy tailored to prognostic factors
21. Prognostic characteristics of surgical stage I endometrial adenocarcinoma
22. Postoperative external pelvic irradiation in carcinoma of the corpus stage I; A controlled clinical trial
23. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma. Clinical and histopathologic study of 540 patients
24. Myometrial penetration of endometrial carcinoma as a prognostic factor for patients receiving pre- or postoperative radiation therapy
25. Risk factors and recurrent patterns in stage I endometrial cancer
26. Postoperative vaginal irradiation with high dose rate afterloading technique in endometrial carcinoma stage I
27. Benefit of external irradiation in pathologic stage I endometrial carcinoma: A prospective clinical trial of 605 patients who received postoperative vaginal irradiation and addition pelvic irradiation in the presence of unfavorable prognostic factors
28. Adjuvant external beam therapy for pathologic stage I and occult stage II endometrial carcinoma
29. The justification of a surgical staging system in endometrial carcinoma
30. Endometrial stage I carcinoma treated with surgery and adjuvant irradiation: A retrospective analysis
31. Improved outcome in patients treated with postoperative radiation therapy for pathologic stage I/II endometrial cancer
32. Excellent long-term survival With absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: Report of a prospective trial
33. High-dose-rate brachytherapy alone post-hysterectomy for endometrial cancer
34. Surgery and postoperative radiation therapy in stage II endoemtrial carcinoma
35. External pelvic radiation therapy in stage IC endometrial carcinoma
36. Postoperative radiotherapy in the management of uterine corpus carcinoma
37. Postoperative adjuvant external-beam radiotherapy in surgical stage I endometrial carcinoma
38. Race and clinical outcome in endometrial carcinoma
39. Correlations between p21 expression and clinicopathological findings, p53 gene and protein alterations, and survival in patients with endometrial carcinoma
40. Multivariate analysis of DNA ploidy, p53 and HER-2.neu as prognostic factors in endometrial cancer
41. bcl-2 and p53 in endometrial adenocarcinoma
42. Expression of the retinoblastoma-related gene RB2/p130 correlated with clinical outcome in endometrial cancer
43. Angiogenesis in cancer, vascular, rheumatoid and other diseases
44. Prognostic significance of angiogenesis and Ki-67, p53 and p21 expression; A population-based endometrial carcinoma study
45. Angiogenesis in endometrial carcinoma
46. Tumor angiogenesis, hepatocyte growth factor and c-met expression in endometrial carcinoma
47. The relationship between nm23, angiogenesis and the metastatic proclivity of node-negative breast cancer